Home/Filings/4/0001209191-21-070999
4//SEC Filing

KANNAN RAJ 4

Accession 0001209191-21-070999

CIK 0001337553other

Filed

Dec 21, 7:00 PM ET

Accepted

Dec 22, 8:07 PM ET

Size

11.2 KB

Accession

0001209191-21-070999

Insider Transaction Report

Form 4
Period: 2021-12-20
KANNAN RAJ
DirectorChief Executive Officer
Transactions
  • Award

    Common Stock

    2021-12-20+215,783215,783 total
  • Award

    Stock Option (right to buy)

    2021-12-20+387,169387,169 total
    Exercise: $8.11Exp: 2031-12-20Common Stock (387,169 underlying)
Footnotes (2)
  • [F1]These shares of Common Stock were granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan (the "Plan") and are scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, in equal installments on each of the first four anniversaries of December 20, 2021.
  • [F2]This option was granted under the Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on December 20, 2022 and as to the remaining underlying shares in substantially equal installments on each of the subsequent 36 monthly anniversaries of December 20, 2022.

Issuer

AERIE PHARMACEUTICALS INC

CIK 0001337553

Entity typeother

Related Parties

1
  • filerCIK 0001778539

Filing Metadata

Form type
4
Filed
Dec 21, 7:00 PM ET
Accepted
Dec 22, 8:07 PM ET
Size
11.2 KB